Authors: Vanasek, J Filip, S Medkova, V Blaha, M Mericka, P Stransky, P Vavrova, J

Citation: J. Vanasek et al., Intensive cyclic chemotherapy with unprocessed whole blood support in advanced breast cancer, NEOPLASMA, 48(1), 2001, pp. 34-38

Authors: Odrazka, K Vanasek, J Vaculikova, M Stejskal, J Filip, S

Citation: K. Odrazka et al., The role of chemotherapy in prostate cancer, NEOPLASMA, 47(4), 2000, pp. 197-203

Authors: Filip, S Vavrova, J Vokurkova, D Blaha, M Vanasek, J

Citation: S. Filip et al., Myeloid differentiation and maturation of SCF+IL-3+IL-11 expanded AC133(+)/CD34(+) cells selected from high-risk breast cancer patients, NEOPLASMA, 47(2), 2000, pp. 73-80

Authors: Filip, S Vanasek, J Blaha, J Mericka, P Vavrova, J Podzimek, K

Citation: S. Filip et al., The increase of the rate of hemopoietic recovery and clinical benefit of the erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) with peripheral blood progenitor cells (PBPC) after intensive cyclic chemotherapy in high-risk breast cancer patients, NEOPLASMA, 46(3), 1999, pp. 166-172